Introduction: Hypertension is the leading preventable risk factor for major cardiovascular diseases worldwide. Recently, compelling evidence has emerged associating hypertension with cerebral microbleeds (CMBs), which are subclinical hemorrhages in the brain resulting from structural abnormalities in the small vessels that supply the brain. In addition to overall elevated blood pressure (BP), elevation in individual parameters such as systolic BP, diastolic BP, pulse pressure and mean arterial pressure could also individually be important risk factors for CMBs. This study aimed to assess the association between CMBs and blood pressure, and assess blood pressure parameters that could be possible risk factors for CMB. Methods: A retrospective case-control study was conducted from August 2021 to September 2022 on patients who underwent MRI due to primary complaints of limb disorders, loss of consciousness, persistent dizziness, and intermittent headaches. The patients were divided according to MRI results into 52 cases (those who had CMBs) and 52 controls (those who had no CMBs). Extracted data were analyzed in SPSS. Chi-square test, binary logistic regression, and Spearman’s correlation analysis were conducted. Results: In total, 104 cases and control patients were assessed, with mean (±SD) age 70.6 ± 8.56 vs 68.9 ± 8.93 years respectively (p > 0.05). CMB patients had more cases of stroke, hyperlipidemia and diabetes than non-CMB patients. Systolic blood pressure (SBP), diastolic blood pressure, pulse pressure (PP) and mean arterial pressure (MAP) were all considerably raised in CMB patients than non-CMBs patients. Blood pressure grades were positively correlated with the severity of CMBs (r = 0.22; p = 0.044). Logistic regression analysis showed that SBP and MAP were independent risk factors for CMBs (age and sex adjusted odds ratio = 1.420; 95% CI: 1.030 - 1.851, and 1.310; 95% CI: 1.011 - 1.631 respectively). Conclusions: In summary, this study found that hypertension was positively correlated with CMBs severity, and that SBP and MAP are independent risk factors for CMBs in patients with hypertension.
References
[1]
Forouzanfar, M.H., et al. (2017) Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. JAMA, 317, 165-182. https://doi.org/10.1001/jama.2016.19043
[2]
GBD 2017 Risk Factor Collaborators (2018) Global, Regional, and National Comparative Risk Assessment of 84 Behavioural, Environmental and Occupational, and Metabolic Risks or Clusters of Risks for 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1923-1994. https://doi.org/10.1016/S0140-6736(18)32225-6
[3]
Mills, K.T., et al. (2016) Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-Based Studies from 90 Countries. Circulation, 134, 441-450. https://doi.org/10.1161/CIRCULATIONAHA.115.018912
[4]
Yin, R., et al. (2022,) Hypertension in China: Burdens, Guidelines and Policy Responses: A State-of-the-Art Review. Journal of Human Hypertension, 36, 126-134. https://doi.org/10.1038/s41371-021-00570-z
[5]
Fuchs, F.D. and Whelton, P.K. (2020) High Blood Pressure and Cardiovascular Disease. Hypertension, 75, 285-292. https://doi.org/10.1161/HYPERTENSIONAHA.119.14240
[6]
Reddy, S.T. and Savitz, S.I. (2020) Hypertension-Related Cerebral Microbleeds. Case Reports in Neurology, 12, 266-269. https://doi.org/10.1159/000508760
[7]
Lyu, L., et al. (2020) Cerebral Microbleeds Are Associated with Blood Pressure Levels in Individuals with Hypertension. Clinical and Experimental Hypertension, 42, 328-334. https://doi.org/10.1080/10641963.2019.1665673
[8]
Elmståhl, S., Ellström, K., Siennicki-Lantz, A. and Abul-Kasim, K. (2019) Association between Cerebral Microbleeds and Hypertension in the Swedish General Population “Good Aging in Skåne” Study. The Journal of Clinical Hypertension, 21, 1099-1107. https://doi.org/10.1111/jch.13606
[9]
Lee, J.S., et al. (2017) Cerebral Microbleeds, Hypertension, and Intracerebral Hemorrhage in Cerebral Autosomal-Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy. Frontiers in Neurology, 8, Article 203. https://www.frontiersin.org/articles/10.3389/fneur.2017.00203 https://doi.org/10.3389/fneur.2017.00203
[10]
Dandapani, B.K., Suzuki, S., Kelley, R.E., Reyes-Iglesias, Y. and Duncan, R.C. (1995) Relation between Blood Pressure and Outcome in Intracerebral Hemorrhage. Stroke, 26, 21-24. https://doi.org/10.1161/01.STR.26.1.21
[11]
Perry, L.A., Rodrigues, M., Al-Shahi Salman, R. and Samarasekera, N. (2019) Incident Cerebral Microbleeds after Intracerebral Hemorrhage. Stroke, 50, 2227-2230. https://doi.org/10.1161/STROKEAHA.118.023746
[12]
Greenberg, S.M., et al. (2009) Cerebral Microbleeds: A Field Guide to their Detection and Interpretation. The Lancet Neurology, 8, 165-174. https://doi.org/10.1016/S1474-4422(09)70013-4
[13]
Buch, S., et al. (2017) Determination of Detection Sensitivity for Cerebral Microbleeds Using Susceptibility-Weighted Imaging. NMR in Biomedicine, 30, e3551. https://doi.org/10.1002/nbm.3551
[14]
Ibrahim, A.A., Ibrahim, Y.A., Darwish, E.A. and Khater, N.H. (2019) Prevalence of Cerebral Microbleeds and Other Cardiovascular Risk Factors in Elderly Patients with Acute Ischemic Stroke. Egyptian Journal of Radiology and Nuclear Medicine, 50, Article No. 38. https://doi.org/10.1186/s43055-019-0034-7
[15]
Napolitano, A., et al. (2022) Cerebral Microbleeds Assessment and Quantification in COVID-19 Patients with Neurological Manifestations. Frontiers in Neurology, 13, Article 884449. https://doi.org/10.3389/fneur.2022.884449
[16]
Henskens, L.H.G., van Oostenbrugge, R.J., Kroon, A.A., de Leeuw, P.W. and Lodder, J. (2008) Brain Microbleeds Are Associated with Ambulatory Blood Pressure Levels in a Hypertensive Population. Hypertension, 51, 62-68. https://doi.org/10.1161/HYPERTENSIONAHA.107.100610
[17]
Yamashiro, K., et al. (2018) Cerebral Microbleeds and Blood Pressure Abnormalities in Parkinson’s Disease. eNeurologicalSci, 10, 5-11. https://doi.org/10.1016/j.ensci.2017.12.002
[18]
Kannel, W.B., Schwartz, M.J. and McNamara, P.M. (1969) Blood Pressure and Risk of Coronary Heart Disease: The Framingham Study. Diseases of the Chest, 56, 43-52. https://doi.org/10.1378/chest.56.1.43
[19]
Tully, P.J., et al. (2020) Association between Blood Pressure Variability and Cerebral Small-Vessel Disease: A Systematic Review and Meta-Analysis. Journal of the American Heart Association, 9, e013841. https://doi.org/10.1161/JAHA.119.013841
[20]
Jiang, Y., Zhang, H., Yang, Y., Sun, Y. and Tian, W. (2022) Pulse Pressure Independent of Mean Arterial Pressure Is Associated with Cardiovascular and All-Cause Mortality in Normotensive Elders: Findings from National Health and Nutrition Examination Survey III 1999-2014. Journal of Vascular Diseases, 1, 113-122. https://doi.org/10.3390/jvd1020013
[21]
Cuschieri, S. (2019) The STROBE Guidelines. Saudi Journal of Anaesthesia, 13, S31-S34. https://doi.org/10.4103/sja.SJA_543_18
[22]
Unger, T., et al. (2020) 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension, 75, 1334-1357. https://doi.org/10.1161/HYPERTENSIONAHA.120.15026
[23]
Vernooij, M.W., et al. (2008) Prevalence and Risk Factors of Cerebral Microbleeds: The Rotterdam Scan Study. Neurology, 70, 1208-1214. https://doi.org/10.1212/01.wnl.0000307750.41970.d9
[24]
Igase, M., et al. (2009) Asymptomatic Cerebral Microbleeds Seen in Healthy Subjects Have a Strong Association with Asymptomatic Lacunar Infarction. Circulation Journal, 73, 530-533. https://doi.org/10.1253/circj.CJ-08-0764
[25]
Fan, Y.H., Zhang, L., Lam, W.W.M., Mok, V.C.T. and Wong, K.S. (2003) Cerebral Microbleeds as a Risk Factor for Subsequent Intracerebral Hemorrhages among Patients with Acute Ischemic Stroke. Stroke, 34, 2459-2462. https://doi.org/10.1161/01.STR.0000090841.90286.81
[26]
Lee, S.-H., Kim, B.J. and Roh, J.-K. (2006) Silent Microbleeds Are Associated with Volume of Primary Intracerebral Hemorrhage. Neurology, 66, 430-432. https://doi.org/10.1212/01.wnl.0000196471.04165.2b
[27]
Kato, H., Izumiyama, M., Izumiyama, K., Takahashi, A. and Itoyama, Y. (2002) Silent Cerebral Microbleeds on T2*-Weighted MRI: Correlation with Stroke Subtype, Stroke Recurrence, and Leukoaraiosis. Stroke, 33, 1536-1540. https://doi.org/10.1161/01.STR.0000018012.65108.86
[28]
Imaizumi, T., Horita, Y., Hashimoto, Y. and Niwa, J. (2004) Dotlike Hemosiderin Spots on T2*-Weighted Magnetic Resonance Imaging as a Predictor of Stroke Recurrence: A Prospective Study. Journal of Neurosurgery, 101, 915-920. https://doi.org/10.3171/jns.2004.101.6.0915
[29]
Horita, Y., et al. (2003) [Analysis of Dot-Like Hemosiderin Spots Using Brain Dock System]. No Shinkei Geka, 31, 263-267. (In Japanese)
[30]
Poels, M.M.F., et al. (2010) Prevalence and Risk Factors of Cerebral Microbleeds. Stroke, 41, S103-S106. https://doi.org/10.1161/STROKEAHA.110.595181
[31]
Hilal, S., et al. (2014) Cerebral Microbleeds and Cognition: The Epidemiology of Dementia in Singapore Study. Alzheimer Disease & Associated Disorders, 28, 106-112. https://doi.org/10.1097/WAD.0000000000000015
[32]
Akoudad, S., et al. (2016) Association of Cerebral Microbleeds with Cognitive Decline and Dementia. JAMA Neurology, 73, 934-943. https://doi.org/10.1001/jamaneurol.2016.1017
